BioCentury
ARTICLE | Preclinical News

Summit identifies two new classes of antibiotics

June 11, 2018 11:12 PM UTC

Summit Therapeutics plc (LSE:SUMM; NASDAQ:SMMT) identified two new types of narrow-spectrum antibiotics targeting new Neisseria gonorrhoeae targets that could help treat gonorrhea.

Summit presented its findings at the American Society for Microbiology Microbe (ASM Microbe) conference in Atlanta...